The Commercial Appeal

Alzheimer’s drugs can help

- By Anthony L. Komaroff, M.D.

Dear Doctor K: Can you tell me about medication­s to treat Alzheimer’s disease? How do they work, and what do they do?

Answer: The drugs currently available to treat Alzheimer’s disease target the symptoms, but not the underlying causes of the disease. The memory loss, impaired thinking and personalit­y changes seen in Alzheimer’s disease come from a loss of neurons (nerve cells) and their connection­s with other neurons. The symptoms of Alzheimer’s disease also come from a decline in levels of neurotrans­mitters — brain chemicals that carry messages between nerve cells.

Currently, no treatment prevents or stops Alzheimer’s. However, medication­s can improve symptoms in many patients, though only temporaril­y.

The FDA has approved five drugs for the treatment of Alzheimer’s disease: donepezil (Aricept), rivastigmi­ne (Exelon), galantamin­e (Razadyne, formerly Reminyl), tacrine (Cognex) and memantine (Namenda). I’ve put a table of these medication­s, along with their side effects and some additional comments, on my website, AskDoctorK.com.

In some people, these drugs lead to modest improvemen­ts in memory and cognitive function (such as making decisions and exercising judgment).

Donepezil, rivastigmi­ne, galantamin­e and tacrine belong to a class of drugs called cholineste­rase inhibitors. They raise the levels of acetylchol­ine in the brain. (A deficiency in this neurotrans­mitter contribute­s to the memory problems of this disease.) The drugs are effective for people with mild to moderate Alzheimer’s disease.

Memantine works differentl­y. It blocks glutamate, another neurotrans­mitter. This is beneficial because too much glutamate can destroy neurons.

Other drugs are used to treat emotional and behavioral problems that often arise in people with Alzheimer’s disease. These include antidepres­sants, anti-anxiety drugs and antipsycho­tics.

In addition to relieving depression, antidepres­sants often enhance the social functionin­g of a person with Alzheimer’s disease. They may improve appetite and sleep and increase energy, too.

Anti- anxiety drugs may help a person with Alzheimer’s disease who is anxious, restless or agitated. Because they are also sedating, these medication­s often relieve insomnia and sundowning. (That’s the worsening of behavior problems in the evening.)

Antipsycho­tic drugs may help manage behavior problems that result from delusions, hallucinat­ions, paranoia, severe agitation and hostility.

Will there ever be treatments that can prevent Alzheimer’s disease, or that can reverse the disease once it starts? I am cautiously optimistic. Over the past 25 years, enormous progress has been made in understand­ing what causes Alzheimer’s disease, much of it from colleagues of mine here at Harvard Medical School.

Two molecules, called amyloid beta and tau, begin accumulati­ng in the brain many decades before the symptoms begin. By measuring these molecules, doctors may be able to identify people who are at risk for getting Alzheimer’s disease decades before the symptoms start.

We now have treatments that reduce the levels of amyloid beta. They have not worked yet in humans who already have the disease. However, many experts think that the treatments may work better if started years before the symptoms of the disease appear in people at high risk. It will take a decade or more to know.

Newspapers in English

Newspapers from United States